We are live on ! Find out more
EXPO icon

Exponent

351 hedge funds and large institutions have $4.5B invested in Exponent in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 121 increasing their positions, 127 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 39

22% more call options, than puts

Call options by funds: $1.75M | Put options by funds: $1.44M

10% more capital invested

Capital invested by funds: $4.1B → $4.5B (+$399M)

1% more funds holding

Funds holding: 349351 (+2)

0.24% more ownership

Funds ownership: 91.39%91.63% (+0.24%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 127

Holders
351
Holders Change
+2
Holders Change %
+0.57%
% of All Funds
5.64%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
49
Increased
121
Reduced
127
Closed
39
Calls
$1.75M
Puts
$1.44M
Net Calls
+$316K
Net Calls Change
-$560K

EXPO Hedge Fund Activity: Q4 2022 in Review

351 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Exponent (EXPO) for Q4 2022, worth a combined $4.5B — up 9.7% from $4.1B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new EXPO positions and 39 closed out — a net gain of 10 holders — while 121 added to existing stakes and 127 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $48M. The largest seller was Ameriprise, cutting an estimated $23.8M.

  • 351 institutional investors held Exponent (EXPO) as of Q4 2022, up from 349 in Q3 2022.
  • Funds reported $4.5B of Exponent stock for Q4 2022, up 9.7% quarter-over-quarter.
  • 49 funds opened new Exponent positions in Q4 2022 and 39 closed out, a net change of +10 holders.
  • The largest Exponent buyer in Q4 2022 was Morgan Stanley, an estimated $48M added.
  • The largest Exponent seller in Q4 2022 was Ameriprise, an estimated $23.8M sold.

Based on aggregated 13F filings for Q4 2022.